NEW YORK, N.Y.—October 12, 2007
"What makes this study so surprising is that people and even doctors have always underestimated the prevalence of arthritis and its profound impact upon people in the prime of their active lives," said Stephen A. Paget, MD, FACP, FACR, physician-in-chief and chairman of the Division of Rheumatology, Hospital for Special Surgery. "This should be considered a 'call to arms' to spread the word about what common arthritis is and how it can dash the hopes of people with it."
Dr. Paget adds that, given the expanded life span and enlarging elderly population who want to continue to be productive and mobile people, there is an urgent need for further support for research into the causes of and cures for arthritis.
With the largest group of rheumatologists in the country, HSS is a world leader in the research and treatment of rheumatic disease.
If you would like to speak with Dr. Paget, please contact:
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.